Cell Culture Automation and Quality Engineering: A Necessary Partnership to Develop Optimized Manufacturing Processes for Cell-Based Therapies

Journal of Laboratory Automation

Volumn 13, Issue 3, 2008, Pages 152-158

  Thomas, R J ^a   Chandra, A ^a   Hourd, P C ^a   Williams, D J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

cell therapy; manufacture; process engineering

Indexed keywords

AUTOMATION; MANUFACTURE; OPTIMIZATION; PROCESS ENGINEERING; QUALITY ASSURANCE;

CELL CULTURE AUTOMATION; CELL THERAPY; QUALITY ENGINEERING;

CELL CULTURE;

ARTICLE; CANCER CELL; CELL CULTURE; CELL CULTURE EQUIPMENT; CELL LINE; CELL POPULATION; CELL THERAPY; CELL TYPE; CONTROLLED STUDY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; LABORATORY AUTOMATION; MESENCHYMAL STEM CELL; OSTEOBLAST; PROCESS OPTIMIZATION; QUALITATIVE ANALYSIS; UMBILICAL CORD;

EID: 42949095385     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2007.12.003     Document Type: Article

References (3)

1. British Standards Institute. Publicly Available Specification 83 (PAS 83)—Guidance on codes of practice, standardised methods and regulations for cell-based therapies, 2006.
2. Archer R. Williams D. J. Why tissue engineering needs process engineering. Nat. Biotechnol. 2005, 23(11), 1353–1355.
3. Gronthos S. Zannettino A. C. W. Graves S. E. Ohta S. Hay S. J. Simmons P. J. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary culture of human bone cells. J. Bone Miner. Res. 1999, 14, 47–56.